Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2011 1
2012 1
2018 1
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
[Retroperitoneal schwannoma: a case report].
Turitto G, Di Bisceglie M, Moraca L, Sasso N, Suriano A, De Angelis CP, Cione G, Angrisani L, Romito S. Turitto G, et al. Among authors: moraca l. Recenti Prog Med. 2011 Jul-Aug;102(7-8):307-9. doi: 10.1701/913.10051. Recenti Prog Med. 2011. PMID: 21779124 Italian.
The new European gold standard treatment for rectum cancer.
De Vita F, Orditura M, Martinelli E, Moraca L, De Chiara A, Catalano G. De Vita F, et al. Among authors: moraca l. Tumori. 2000 Sep-Oct;86(5 Suppl 2):S26-9. Tumori. 2000. PMID: 11195299 Review. No abstract available.
Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study.
Fedele P, Landriscina M, Moraca L, Cusmai A, Gnoni A, Licchetta A, Guarini C, Lanotte L, Pappagallo MN, Melaccio A, Giordano G, Maselli FM, Pinto A, Giuliani F, Chiuri V, Giotta F, Gadaleta-Caldarola G. Fedele P, et al. Among authors: moraca l. Cancers (Basel). 2024 Oct 10;16(20):3442. doi: 10.3390/cancers16203442. Cancers (Basel). 2024. PMID: 39456537 Free PMC article.
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial.
De Placido S, Gallo C, De Laurentiis M, Bisagni G, Arpino G, Sarobba MG, Riccardi F, Russo A, Del Mastro L, Cogoni AA, Cognetti F, Gori S, Foglietta J, Frassoldati A, Amoroso D, Laudadio L, Moscetti L, Montemurro F, Verusio C, Bernardo A, Lorusso V, Gravina A, Moretti G, Lauria R, Lai A, Mocerino C, Rizzo S, Nuzzo F, Carlini P, Perrone F; GIM Investigators. De Placido S, et al. Lancet Oncol. 2018 Apr;19(4):474-485. doi: 10.1016/S1470-2045(18)30116-5. Epub 2018 Feb 23. Lancet Oncol. 2018. PMID: 29482983 Clinical Trial.
Standard Versus Reduced CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: An Observational Multicenter Study.
Fedele P, Landriscina M, Moraca L, Gadaleta-Caldarola A, Cusmai A, Giuliani F, Chiuri V, Giotta F, Pinto A, Mirisola V, Gadaleta-Caldarola G. Fedele P, et al. Among authors: moraca l. J Clin Med. 2024 Dec 6;13(23):7441. doi: 10.3390/jcm13237441. J Clin Med. 2024. PMID: 39685899 Free PMC article.